415 related articles for article (PubMed ID: 36279071)
1. Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites.
Zhang W; Dong XY; Huang R
Transl Stroke Res; 2023 Dec; 14(6):811-828. PubMed ID: 36279071
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke.
Chidambaram SB; Rathipriya AG; Mahalakshmi AM; Sharma S; Hediyal TA; Ray B; Sunanda T; Rungratanawanich W; Kashyap RS; Qoronfleh MW; Essa MM; Song BJ; Monaghan TM
Cells; 2022 Apr; 11(7):. PubMed ID: 35406804
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.
Yin J; Liao SX; He Y; Wang S; Xia GH; Liu FT; Zhu JJ; You C; Chen Q; Zhou L; Pan SY; Zhou HW
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26597155
[TBL] [Abstract][Full Text] [Related]
4. Role of the Gut Microbiota in Stroke Pathogenesis and Potential Therapeutic Implications.
Yamashiro K; Kurita N; Urabe T; Hattori N
Ann Nutr Metab; 2021; 77 Suppl 2(Suppl 2):36-44. PubMed ID: 34107468
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.
Manolis AA; Manolis TA; Melita H; Manolis AS
Curr Med Chem; 2022; 29(23):4050-4077. PubMed ID: 34961453
[TBL] [Abstract][Full Text] [Related]
6. Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target.
Turpin T; Thouvenot K; Gonthier MP
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136564
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota.
Chen R; Xu Y; Wu P; Zhou H; Lasanajak Y; Fang Y; Tang L; Ye L; Li X; Cai Z; Zhao J
Pharmacol Res; 2019 Oct; 148():104403. PubMed ID: 31425750
[TBL] [Abstract][Full Text] [Related]
8. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.
Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes.
Tan C; Wu Q; Wang H; Gao X; Xu R; Cui Z; Zhu J; Zeng X; Zhou H; He Y; Yin J
JPEN J Parenter Enteral Nutr; 2021 Mar; 45(3):518-529. PubMed ID: 32473086
[TBL] [Abstract][Full Text] [Related]
10. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Sitkin SI; Tkachenko EI; Vakhitov TY
Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
[TBL] [Abstract][Full Text] [Related]
11. Dietary lipids, gut microbiota and lipid metabolism.
Schoeler M; Caesar R
Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword.
Peh A; O'Donnell JA; Broughton BRS; Marques FZ
Stroke; 2022 May; 53(5):1788-1801. PubMed ID: 35135325
[TBL] [Abstract][Full Text] [Related]
13. Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome.
Chae YR; Lee YR; Kim YS; Park HY
J Microbiol Biotechnol; 2024 Apr; 34(4):747-756. PubMed ID: 38321650
[TBL] [Abstract][Full Text] [Related]
14. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
16. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites.
Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A
Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential.
Zhu M; Dagah OMA; Silaa BB; Lu J
Antioxidants (Basel); 2023 Aug; 12(9):. PubMed ID: 37759983
[TBL] [Abstract][Full Text] [Related]
18. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD).
Hemmati M; Kashanipoor S; Mazaheri P; Alibabaei F; Babaeizad A; Asli S; Mohammadi S; Gorgin AH; Ghods K; Yousefi B; Eslami M
Life Sci; 2023 Sep; 329():121947. PubMed ID: 37463653
[TBL] [Abstract][Full Text] [Related]
19. The Bridge Between Ischemic Stroke and Gut Microbes: Short-Chain Fatty Acids.
Fang Z; Chen M; Qian J; Wang C; Zhang J
Cell Mol Neurobiol; 2023 Mar; 43(2):543-559. PubMed ID: 35347532
[TBL] [Abstract][Full Text] [Related]
20. Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease.
Al Samarraie A; Pichette M; Rousseau G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
